Loading...
Genetic Variation (CHRNA5), Medication (Combination Nicotine Replacement Therapy vs. Varenicline) and Smoking Cessation()
OBJECTIVE: Recent evidence suggests that the efficacy of smoking cessation pharmacotherapy can vary across patients based on their genotypes. This study tests whether the coding variant rs16969968 in the CHRNA5 nicotinic receptor gene predicts the effects of combination nicotine replacement therapy...
Na minha lista:
| Udgivet i: | Drug Alcohol Depend |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4537319/ https://ncbi.nlm.nih.gov/pubmed/26142345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2015.06.022 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|